[Form 4] Masimo Corporation Insider Trading Activity
Charles Dadswell, a director of Masimo Corporation (MASI), reported equity awards granted on August 18, 2025. The filing shows 2,273 restricted stock units (RSUs), each representing a contingent right to one share, and a non-qualified stock option covering 5,104 shares with an exercise price of $153.93. The RSUs vest ratably over four years with 25% vesting on each anniversary of the grant date. The option vests over five years with 20% vesting on each anniversary and is exercisable as it vests.
The Form 4 was filed individually and signed by an attorney-in-fact on behalf of the reporting person. All information in this summary is taken directly from the Form 4 content.
- Equity grants disclosed: 2,273 RSUs and an option for 5,104 shares, providing clear compensation detail
- Long-term vesting schedules: RSUs vest over four years and the option vests over five years, aligning incentives
- Option exercise price disclosed: $153.93, which could delay intrinsic value until stock price exceeds that level
- Vesting delays liquidity: Both awards vest over multi-year schedules, meaning no immediate share receipt
Insights
TL;DR Director received standard multi-year equity awards: RSUs and time‑vesting options, reflecting typical compensation not indicating immediate market-moving changes.
The disclosed grants total 2,273 RSUs and a non‑qualified option for 5,104 shares at an exercise price of $153.93. Vesting schedules (four years for RSUs, five years for the option) spread potential dilution and align incentives long‑term. This is a routine insider compensation disclosure and does not by itself provide revenue, earnings, or material corporate-event information.
TL;DR Reported grants follow customary multi-year vesting patterns for directors and signal retention/incentive alignment rather than a governance red flag.
The Form 4 explicitly states the RSUs vest 25% annually over four years and the option vests 20% annually over five years, with exercisability tied to vesting. The filing is individual, properly executed by an attorney‑in‑fact, and contains clear explanatory remarks. From a governance perspective, the structure is conventional and provides long‑term alignment between the director and shareholders.